Kappa Santé is a CRO founded by Dr Stéphane Schück in December 2003. It specializes in the processing of real-life data to evaluate health products and interventions, health programs and policies, and therapeutic innovations. The evaluation of these strategies is based on the analysis of existing data (database, SNDS data or already constituted cohorts) and on the setting up of new cohorts via observational or interventional studies. Since its creation, Kappa Santé has conducted more than a hundred epidemiological studies in various pathological fields, from hematology, oncology, dermatology, neurology, mental health, infectious diseases, nephrology and Alzheimer's disease.
In 2017, Kappa Santé has founded Kap Code, which designs and develops innovative digital solutions to serve the patient, scientific research and the pharmaceutical industry. Kap Code and Kappa Santé are also partners on projects such as Epilogue and CONFINS.